“Covid-19 has led to an increase in Doliprane consumption and to winter illnesses,” observes Pierre Demay, manager of the station pharmacy for ten years. Several forms of Doliprane are therefore missing from some pharmacies. But there is nothing to worry about, we are reassured, this Friday April 22nd in the pharmacies in downtown Nevers.
Alternatives to Doliprane
“I’ve been missing Doliprane 1,000 capsules for a few months. I received some, but in small quantities,” explains Pierre Demay. According to the pharmacist, the situation does not only affect Sanofi’s drug. He speaks of forty other products: “In over thirty years of practice, I have never experienced so many supply interruptions,” he says. He has no choice but to be patient: “In the end we get them, they arrive within three weeks or a month. For the patients, we replace them with other things.”
At the Clavilier Pharmacy “a small amount of Doliprane in capsules has arrived in small quantities this week”, we are reassured and remind that there are alternatives for adults: Efferalgan or Dafalgan.
According to Benjamin Brodat, head of the Carnot pharmacy, the hardest part is behind us: “In March we had trouble getting supplies. But it slowly came back. And we had stock, so there wasn’t really a shortage,” he explains. The most affected forms were Doliprane 1,000 in capsules and Liquiz for children in 200 and 300 mg. Here, too, the pharmacist offers “alternatives with other laboratories”. For him, there can be no question of scarcity: “There is no real concern,” he smiles behind the mask.
Post Office. “Our priority is to get out of this situation as soon as possible,” Sanofi said in an April 12 letter to pharmacists. Delivery difficulties are to be expected until June.
Three reasons. Sanofi highlights a significant and steady increase in orders; Delays in delivery of packaging items by its suppliers and a global shortage of raw and auxiliary materials. “The last two factors require us to adjust our production schedules and the deadlines communicated to you on a daily basis,” Sanofi apologizes to pharmacists.